Larvol Delta - The-Phase-1b-study-Abstract-1782P-enrolled-23-adults-with-obesity-and-prediabetes-in-a-randomized-doubleblind-placebocontrolled-design-with-an-optional-openlabel-extension-OLE

ATX-304 - Cambrian Biopharma

https://www.businesswire.com/news/home/20260618220426/en/Cambrian-Bio-Presents-Positive-Human-Translational-Data-for-ATX-304-the-First-AMPK-Network-Activator-at-the-American-Diabetes-Associations-86th-Scientific-Sessions?feedref=JjAwJuNHiystnCoBq_hl-W8j9Oi60kFTomUxRDB8jhBmQVX0ensKJE0BJucsY2EHrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3l7muWvj2Vtof9nl3SayFmdRzAC4_rGwOLNoA4bcgbFNw%3D%3D

Jun 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next